Semaglutide Brand Names: Wegovy, Ozempic and Rybelsus Explained
Semaglutide is a prescription medicine that belongs to the GLP-1 receptor agonist class. It has become one of the most…
Tag: Drugs
Top Obesity Biotech Companies in 2026: Beyond Novo Nordisk and Eli Lilly
The obesity drug race is no longer limited to Novo Nordisk and Eli Lilly. A growing group of biotech companies…
Why Is It So Hard to Stop Eating Fatty Foods? A New Brain Study Offers a Clue
Why can some people keep eating fatty foods even after they have consumed enough calories? New research suggests part of…
Eli Lilly’s Weight-Loss Pill Foundayo Secures First European Approval in Britain
Eli Lilly has secured a major win in the fast-growing market for oral weight-loss drugs after Britain became the first…
Aleniglipron GLP-1 Pill Shows 12.1% Weight Loss in 36 Weeks
A new once-daily oral GLP-1 drug is adding momentum to the rapidly changing obesity-treatment market. In a Phase 2b trial…
List of GLP-1 Drugs: 2026 Update
GLP-1 drugs have become some of the most closely watched medicines in diabetes and obesity treatment. These medicines mimic the…
How Much Does the New Oral GLP-1 Drug Cost in 2026?
The obesity-drug market has entered a new phase in 2026: GLP-1 weight-loss medicines are moving from weekly injections to daily…